WANBURY
Quarterly Results Analysis [Sep2024]
WANBURY Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹161 Cr | ₹131 Cr | ₹139 Cr | ₹145 Cr | ₹144 Cr | ₹146 Cr | ₹133 Cr | ₹126 Cr |
Expenses | ₹141 Cr | ₹120 Cr | ₹121 Cr | ₹124 Cr | ₹127 Cr | ₹133 Cr | ₹119 Cr | ₹119 Cr |
Operating Income | ₹20 Cr | ₹11 Cr | ₹18 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹14 Cr | ₹6 Cr |
Other Income | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹-2 Cr | ₹0 Cr |
Interest | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹8 Cr | ₹7 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹8 Cr | ₹1 Cr | ₹34 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹-3 Cr |
Profit After Tax | ₹8 Cr | ₹1 Cr | ₹34 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹-3 Cr |
EPS | ₹2.45 | ₹0.32 | ₹10.27 | ₹3.14 | ₹2.25 | ₹1.43 | ₹0.31 | ₹-1.00 |
Industry Peers & Returns | 1W | 1M | 1Y |
WANBURY | -7.8% | 15.5% | 100.9% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
CIPLA | -1.1% | -0.3% | 20.7% |
DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
LUPIN | 0.9% | 7.2% | 72.7% |
WANBURY Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 22.94 % |
Y-o-Y | 11.58 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹161 Cr | 22.94 | |
Jun2024 | ₹131 Cr | -5.95 | |
Mar2024 | ₹139 Cr | -4.19 | |
Dec2023 | ₹145 Cr | 0.72 | |
Sep2023 | ₹144 Cr | -1.25 | |
Jun2023 | ₹146 Cr | 10.01 | |
Mar2023 | ₹133 Cr | 5.72 | |
Dec2022 | ₹126 Cr | - |
WANBURY Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 82.33 % |
Y-o-Y | 15.37 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹20 Cr | 82.33 | |
Jun2024 | ₹11 Cr | -39.58 | |
Mar2024 | ₹18 Cr | -14.11 | |
Dec2023 | ₹21 Cr | 21.92 | |
Sep2023 | ₹17 Cr | 29.94 | |
Jun2023 | ₹13 Cr | -5.75 | |
Mar2023 | ₹14 Cr | 119.38 | |
Dec2022 | ₹6 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 48.27 % |
Y-o-Y | 3.33 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 12.41% | 48.27 | |
Jun2024 | 8.37% | -35.76 | |
Mar2024 | 13.03% | -10.32 | |
Dec2023 | 14.53% | 20.98 | |
Sep2023 | 12.01% | 31.69 | |
Jun2023 | 9.12% | -14.37 | |
Mar2023 | 10.65% | 107.60 | |
Dec2022 | 5.13% | - |
WANBURY Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 673.29 % |
Y-o-Y | 8.92 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹8 Cr | 673.29 | |
Jun2024 | ₹1 Cr | -96.92 | |
Mar2024 | ₹34 Cr | 227.42 | |
Dec2023 | ₹10 Cr | 39.53 | |
Sep2023 | ₹7 Cr | 57.01 | |
Jun2023 | ₹5 Cr | 361.97 | |
Mar2023 | ₹1 Cr | Positive | |
Dec2022 | ₹-3 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 529.11 % |
Y-o-Y | -2.55 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 4.97 % | 529.11 | |
Jun2024 | 0.79 % | -96.73 | |
Mar2024 | 24.13 % | 241.78 | |
Dec2023 | 7.06 % | 38.43 | |
Sep2023 | 5.1 % | 58.88 | |
Jun2023 | 3.21 % | 322.37 | |
Mar2023 | 0.76 % | Positive | |
Dec2022 | -2.61 % | - |
WANBURY Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 665.63 % |
Y-o-Y | 8.89 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹2.45 | 665.63 | |
Jun2024 | ₹0.32 | -96.88 | |
Mar2024 | ₹10.27 | 227.07 | |
Dec2023 | ₹3.14 | 39.56 | |
Sep2023 | ₹2.25 | 57.34 | |
Jun2023 | ₹1.43 | 361.29 | |
Mar2023 | ₹0.31 | Positive | |
Dec2022 | ₹-1 | - |
You may also like the below Video Courses